Similar Jobs
Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.
We are seeking a Scientist III to join our High Throughput Screening (HTS) wet-lab team at Ginkgo Datapoints. This is a wet-lab scientist role focused on assay design and biological experimentation, using automation as a tool to increase throughput. Ideal candidates are passionate about lab automation, assay development, high-throughput screening, process optimization, and are eager to onboard assays onto workcells and scale screening platforms. Candidates should be excited to work in a highly collaborative, cross-functional environment.
Responsibilities
- Design, optimize, and execute assays for antibody developability and functional genomics products.
- Analyze, interpret, and document experimental data while maintaining accurate and detailed records.
- Lead the development and automation of biological assays in collaboration with assay subject matter experts.
- Contribute to the design, buildout, and application of automated workflows and workcell-based screening pipelines to support Datapoints products.
- Test, maintain, and troubleshoot robotic platforms and automation instruments used to execute complex biological workflows.
- Provide technical training and support to lab personnel on automation processes, equipment, and technologies.
- Work independently and in an agile, self-directed manner to complete tasks and projects on defined timelines.
Minimum Requirements
- BS or MS in biology, biochemistry, bioengineering, pharmacology, or related fields.
- 4-8 years of experience in an industry laboratory setting, ideally in a high-throughput screening team with exposure to both screening and automation development.
Preferred Capabilities and Experience
- Strong background in mammalian cell culture, transfections, or cell-based assays.
- Familiarity with DOE-based assay development and statistical optimization techniques.
- Extensive experience with automation platforms (e.g., HRB workcells, Prime, Lynx, Hamilton).
- Proven troubleshooting skills across assay development and automation systems; comfortable adapting to new tech and changing workflows.
- Ability to work in a fast-paced, dynamic team environment with a sense of urgency, creativity, and focus on deliverables.
To learn more about Ginkgo, visit www.ginkgobioworks.com/press/ or check out some curated press below:
- What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)
- Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)
- Ginkgo Bioworks CEO on scaling up Covid-19 testing: ‘If we try, we can win’ (CNBC)
- Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)
- Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
- Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)
- The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
- Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
- Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
- Can This Company Convince You to Love GMOs? (The Atlantic)
We also feel that it’s important to point out the obvious here – there’s a serious lack of diversity in our industry, and that needs to change. Our goal is to help drive that change. Ginkgo is deeply committed to diversity, equity, and inclusion in all of its practices, especially when it comes to growing our team. Our culture promotes inclusion and embraces how rewarding it is to work with people from all walks of life.
We’re developing a powerful biological engineering platform, so we must remain mindful of the many ways our technology can – and will – impact people around the world. We care about how our platform is used, and having a diverse team to build it gives us the best chance that it’s something we’ll be proud of as it continues to grow. Therefore, it’s critical that we incorporate the diverse voices and visions of all those who play a role in the future of biology.
It is the policy of Ginkgo Bioworks to provide equal employment opportunities to all employees, employment applicants, and EOE disability/vet.
Privacy Notice
I understand that I am applying for employment with Ginkgo Bioworks and am being asked to provide information in connection with my application. I further understand that Ginkgo gathers this information through a third-party service provider and that Ginkgo may also use other service providers to assist in the application process. Ginkgo may share my information with such third-party service providers in connection with my application and for the start of employment. Ginkgo will treat my information in accordance with Ginkgo's Privacy Policy. By submitting this job application, I am acknowledging that I have reviewed and agree to Ginkgo's Privacy Policy as well as the privacy policies of the third-party service providers used by Ginkgo's associated with the application process.
Ginkgo Bioworks Boston, Massachusetts, USA Office
27 Drydock Ave, 8th floor, Boston, MA, United States, 02210
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
